Literature DB >> 8489856

Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?

A J Coats.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489856      PMCID: PMC1025036          DOI: 10.1136/hrt.69.4.282

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  5 in total

1.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Comparison of captopril and enalapril in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; M Yushak; N Medina
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

3.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

4.  Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br Heart J       Date:  1993-04

5.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

Authors:  K Swedberg; P Held; J Kjekshus; K Rasmussen; L Rydén; H Wedel
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.